Long-term Effects of Octreotide on Liver Volume in Patients With Polycystic Kidney and Liver Disease-Reference-Cited by-同舟云学术

Long-term Effects of Octreotide on Liver Volume in Patients With Polycystic Kidney and Liver Disease

Published:2016-07 Issue:7 Volume:14 Page:1022-1030.e4
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Pisani Antonio,Sabbatini Massimo,Imbriaco Massimo^ORCID,Riccio Eleonora,Rubis Nadia,Prinster Anna^ORCID,Perna Annalisa,Liuzzi Raffaele,Spinelli Letizia,Santangelo Michele^ORCID,Remuzzi Giuseppe,Ruggenenti Piero,Pisani A.,Sabbatini M.,Ruggenenti P.,Remuzzi G.,Pisani A.,Visciano B.,Amicone M.,Dipietro R.,Mozzillo G.,Riccio E.,Rossano R.,Sabbatini M.,Spinelli L.,Santangelo M.,Rubis N.,Diadei O.,Calini W.,Villa A.,Sabatella M.,Ene-Iordache B.,Carminati S.,Martinetti D.,Giuliano G.A.,Perna A.,Liuzzi R.,Remuzzi A.,Imbriaco M.,Prinster A.,Altiero M.,Boccardo P.,Peracchi S.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases;Van Keimpema;Liver Int,2011

2. Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1;Reynolds;Am J Hum Genet,2000

3. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort;Bae;Clin J Am Soc Nephrol,2006

4. Evaluating health-related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume;Wijnands;Liver Int,2014

5. Hepatic venous outflow obstruction in autosomal dominant polycystic kidney disease;Torres;J Am Soc Nephrol,1994

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease;Orphanet Journal of Rare Diseases;2024-04-26

2. Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights;Expert Opinion on Investigational Drugs;2024-04-21

3. ACG Clinical Guideline: Focal Liver Lesions;American Journal of Gastroenterology;2024-01-26

4. Extrarenal Manifestations: Polycystic Liver Disease and Its Complications;Advances in Kidney Disease and Health;2023-09

5. Polycystic liver disease: an overview of clinical manifestations, diagnosis, and treatment;Kosin Medical Journal;2023-06-30